Hedge funds are increasingly betting against AI-related stocks, with a 12% increase in short bets in July, according to Hazeltine. Companies like Super Micro Computer, Coreweave, and Nebius Group saw increased short positions, while hedge funds reduced their long positions in Nvidia but still maintained a bet on rising shares.
Novo Nordisk is taking a different approach, partnering with Amazon Web Services to accelerate drug discovery using artificial intelligence. The company's CEO, Mike Doustdar, believes AI can reduce the typical 15-year medicine development timeline to just five years.
Other companies are also leveraging AI for various purposes. SoundHound AI launched a new platform called OASYS, which allows businesses to build voice-activated AI agents, and raised its full-year revenue forecast for 2026 and 2027. Hanjin, a South Korean logistics giant, has invested in AI training for employees, logging 2,329 hours of training in the first half of the year.
AI is also being used in sales optimization, with Outcraft AI focusing on tools that optimize or analyze sales interactions for e-commerce merchants. However, the use of AI in book collections has sparked controversy, with AI firms quietly purchasing large collections of rare and out-of-print books.
On the job front, Resume Now has identified the top 10 jobs that are less likely to be replaced by AI, including firefighters, airline pilots, and structural iron and steel workers. Meanwhile, a new font called ShieldFont has been designed to make webpages unreadable by AI scrapers.
Key Takeaways
• Hedge funds increased short positions in AI-related stocks by 12% in July, with companies like Super Micro Computer, Coreweave, and Nebius Group seeing increased short positions. \n• Novo Nordisk partnered with Amazon Web Services to accelerate drug discovery using AI, aiming to reduce the medicine development timeline from 15 years to 5 years. \n• SoundHound AI launched a new platform called OASYS, which allows businesses to build voice-activated AI agents. \n• Hanjin invested in AI training for employees, logging 2,329 hours of training in the first half of the year. \n• Outcraft AI is focusing on sales optimization for Shopify apps. \n• AI firms are quietly purchasing large collections of rare and out-of-print books, sparking controversy in the book community. \n• Resume Now identified the top 10 jobs that are less likely to be replaced by AI, including firefighters, airline pilots, and structural iron and steel workers. \n• A new font called ShieldFont has been designed to make webpages unreadable by AI scrapers. \n• China's quantitative trading funds are facing scrutiny from retail traders and regulators. \n• AI can bring significant cost savings to clinical trials by streamlining the process and improving accuracy.Hedge Funds Bet Against AI Stocks
Hedge funds increased their short positions in AI-related stocks in July, according to Hazeltree. This move was part of a broader market trend where investors reassessed their approach to the AI sector due to concerns over high valuations and revenue growth. Companies like Super Micro Computer, Coreweave, and Nebius Group saw increased short positions. Hedge funds also reduced their long positions in Nvidia while increasing short positions, but still maintained a bet on rising shares in the chipmaker.
Hedge Funds Increase Short Bets on AI Stocks
Hedge funds increased their short bets on AI-related stocks by 12% in July, according to Hazeltree. The number of hedge funds holding short positions in AI-related stocks also increased by 15%. This shift in sentiment was part of a broader trend in the market, with investors becoming increasingly bearish on the sector.
Novo Nordisk Bets on AI for Drug Discovery
Novo Nordisk has partnered with Amazon Web Services to accelerate drug discovery using artificial intelligence. The company's CEO, Mike Doustdar, believes AI can reduce the typical 15-year medicine development timeline to just five years. This partnership aims to supercharge scientific researchers to find cures faster.
Pharmaceutical CEO Bets on AI for Next-Gen Drugs
Novo Nordisk President and CEO Mike Doustdar discusses the company's collaboration with artificial intelligence to accelerate drug discovery and development. The company is using AI to improve the efficiency of its drug development process.
SoundHound AI Stock Analysis
SoundHound AI stock has plunged 67% from its all-time high. Despite this, the company has launched a new platform called OASYS, which allows businesses to build voice-activated AI agents. SoundHound also raised its full-year revenue forecast for 2026 and 2027.
Hanjin Invests in AI Training for Employees
Hanjin, a South Korean logistics giant, has logged 2,329 hours of employee AI training in the first half of the year. The company has built out its AI infrastructure and plans to expand hands-on training focused on AI agent development and data analytics.
Outcraft AI Focuses on Sales Optimization
Outcraft AI is highlighting its focus on sales optimization for Shopify apps. The company is likely working on tools that optimize or analyze sales interactions for e-commerce merchants.
AI Firms Buying Rare Books Spark Controversy
AI firms have been quietly purchasing large collections of rare and out-of-print books, sparking controversy in the book community. Booksellers and collectors argue that this practice threatens the preservation of rare and valuable books.
Top 10 AI-Proof Jobs Revealed
Resume Now has identified the top 10 jobs that are less likely to be replaced by AI. The list includes firefighters, airline pilots, and structural iron and steel workers. These jobs require skills that are difficult to automate, such as endurance, strength, and human interaction.
New Font Blocks AI Scrapers
A new font called ShieldFont has been designed to make webpages unreadable by AI scrapers. The font uses techniques such as ligatures and contextual alternates to create a readable webpage for humans but nonsensical text for machines.
China's Quant Funds Face Scrutiny
China's quantitative trading funds have grown rapidly in recent years, but they are now facing scrutiny from retail traders and regulators. These funds use AI to make trading decisions, but their strategies are not always transparent.
AI Brings Savings to Clinical Trials
A new study has found that the use of AI in clinical trials can lead to significant cost savings. The study found that AI can help streamline the process, reduce manual data entry, and improve the accuracy of trial results.
Sources
- Hedge Funds Raise Short Bets on AI Stocks as Chip Shares Plunge
- Hedge funds upped short AI bets in July, Hazeltree says
- AI will have 'profound future' in healthcare: Novo Nordisk
- Pharmaceutical CEO bets on AI for next-gen drugs
- Should You Buy SoundHound AI Stock After Its 67% Plunge? The Answer Might Surprise You.
- Hanjin Logs 2,329 Hours of Employee AI Training in H1, Shifts Focus to AI Agent Development in H2
- Outcraft AI Highlights Focus on Sales Optimization for Shopify Apps
- Here’s a balm if the idea of destroying books to train AI breaks your heart
- These 10 'AI proof' jobs have one thing in common. See list
- New font turns ordinary webpages into nonsense for AI scrapers
- What are China’s quantitative trading funds, and why are they so controversial?
- AI brings savings to clinical trials: study
Comments
Please log in to post a comment.